Improved detection of familial hypercholesterolemia by determining low density lipoprotein receptor expression in mitogen-induced proliferating lymphocytes

Journal of Lipid Research

Volumn 39, Issue 11, 1998, Pages 2261-2270

  Chan, Pak Cheung ^a   Edwards, Alun ^a   Lafrenière, René ^a   Parsons, Howard G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Familial hypcrcholesterolemia; Flow cytometry; Low density lipoprotein receptor; Mitogen stimulation; Proliferating lymphocytes

Indexed keywords

CHOLESTEROL ACYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INTERLEUKIN 2 RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGENIC AGENT; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ;

ARTICLE; CARDIOVASCULAR RISK; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME REPRESSION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FLOW CYTOMETRY; GENE MUTATION; GENETIC RISK; HUMAN; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MALE; MITOGENESIS; MITOGENICITY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD14; CELL SEPARATION; CHILD; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; MITOGENS; RECEPTORS, INTERLEUKIN-2; RECEPTORS, LDL; TETRADECANOYLPHORBOL ACETATE; UP-REGULATION;

EID: 0031724980     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Goldstein, J. L., and M. S. Brown. 1982. The LDL receptor defect in familial hypercholesterolemia: implications for pathogenesis and therapy. Med. Clin. North. Am. 66: 335-362.
2. Fagge, C. H. 1973. Xanthomatous diseases of the skin. Trans. Pathol. Soc. London. 24: 242-252.
3. Brown, M. S., and J. L. Goldstein. 1975. Familial hypercholesterolemia: genetic, biochemical and pathological considerations. Adv. Intern. Med. 20: 271-296.
4. Slack, J. 1979. Inheritance of familial hypercholesterolemia. Atheroscler. Rev. 5: 35-66.
5. Yamamoto, A., T. Kamiya, T. Yamamura, S. Yokoyama, Y. Horiguchi, T. Funahashi, A. Kawaguchi, Y. Miyake, S. Beppu, K. Ishikawa, et al. 1989. Clinical features of familial hypercholesterolemia. Arterioscl. Suppl. I: 66-74.
6. Reunanen, A., A. Aromaa, K. Pyorala, S. Punsar, J. Maatela, and P. Knekt. 1983. The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience. Publ. Social Insurance Inst., AL:21. 67-81. Helsinki, Finland.
7. Stone, N. J., R. I. Levy, P. S. Fredrickson, and J. Vener. 1974. Coronary artery disease in 116 kindred with familial type II hypercholesterolemia. Circulation. 49: 476-488.
8. Scientific Steering Committee on behalf of the Simon Broome Register Group. 1991. Risk of fatal coronary heart disease in familial hypercholesterolemia. Br. Med. J. 303: 893-896.
9. Soutar, A. K. 1992. Familial hypercholesterolemia and LDL receptor mutations. J. Intern. Med. 231: 633-641.
10. Kotze, M. J., F. Langehhoven, L. Theart, M. P. Marx, and C. J. Oosthuizen. 1994. Report on a molecular diagnostic service for familial hypercholesterolemia in Afrikaners. Genet. Couns. 5: 15-21.
11. Loren, T. P., H. Sundvold, O. K. Rodningen, S. Tonstad, K. Solberg, L. Ose, and K. Berg. 1995. Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia. Hum. Genet. 95: 671-676.
12. Goldstein, J. L., H. H. Hobbs, and M. S. Brown. 1995. Familial hypercholesterolemia. In The Metabolic Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 1981-2030.
13. Hobbs, H. H., D. W. Russell, M. S. Brown, and J. L. Goldstein. 1990. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu. Rev. Genet. 24: 133-170.
14. Goldstein, J. L., and M. S. Brown. 1979. The LDL receptor locus and the genetics of familial hypercholesterolemia. Annu. Rev. Genet. 13: 259-289.
15. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of LDL in cultured cells. Methods Enzymol. 98: 241-260.
16. Benhamamouch, S., J. P. Kusnierz, G. Agnani, D. Marzin, J. M. Lecerf, J. C. Fruchart, and V. Clavey. 1988. Determination of the LDL receptor binding capacity of human lymphocytes by immunocytofluorimetric assay. Biochim. Biophys. Acta. 1002: 45-53.
17. Ho, Y. K., M. S. Brown, D. W. Bilheimer, and J. L. Goldstein. 1976. Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes. J. Clin. Invest. 59: 1465-1474.
18. Roach, P. D., J. Hosking, P. M. Clifton, R. Bais, B. Kusenic, P. Coyle, M. B. Wight, D. W. Thomas, and P. J. Nestel. 1993. The effects of hypercholesterolemia, simvastatin and dietary fat on the low density lipoprotein receptor of unstimulated mononuclear cells. Atherosclerosis. 103: 245-254.
19. Chait, A., K. Henze, T. Mazzone, M. Jensen, and W. Hammond. 1982. Low density lipoprotein receptor activity in freshly isolated human monocytes and lymphocytes. Metabolism. 31: 721-727.
20. Schmitz, G., T. Bruning, E. Kovacs, and S. Barlage. 1993. Fluorescence flow cytometry of human leukocytes in the detection of LDL receptor defects in the differential diagnosis of hypercholesterolemia. Arterioscler. Thromb. 13: 1053-1065.
21. Traill, K. N., G. Jurgens, D. Schonitzer, G. Bock, L. Huber, and G. Wick. 1986. FACS analysis of low density lipoprotein binding to human peripheral blood lymphocytes. Immunoreg. Aging. 1: 185-190.
22. Cuthbert, J. A., C. A. East, D. W. Bilheimer, and P. E. Lipsky. 1986. Detection of familial hypercholesterolemia by assaying functional low density lipoprotein receptors on lymphocytes. N. Engl. J. Med. 314: 879-883.
23. Cuthbert, J. A., and P. E. Lipsky. 1989. Identification of low density lipoprotein receptor abnormalities by assaying functional receptors on proliferating lymphocytes. Arteriosclerosis Suppl. I. 9: I43-49.
24. Sakuma, N., S. Iwata T. Ichikawa, and T. Fujinami. 1992. Assessment of functional low-density-lipoprotein receptor on lymphocytes by a simplified method using culture medium with lipoprotein-free fetal calf serum and pravastatin. Clin. Biochem. 25: 368-370.
25. Lestavel-Delattre, S., S. Benhamamouch, G. Agnani, G. Luc, J. M. Bard, T. Brousseau, C. Billardon, J. P. Kusnierz, J. L. De Gennes, J. C. Fruehart, and V. Clavey. 1994. Evidence of non-deficient low density lipoprotein receptor patients in a pool of subjects with clinical familial hypercholesterolemia profile. Metabolism. 43: 397-402.
26. Ranganathan, S., H. Hattori, and M. L. Kashyap. 1995. A rapid flow cytometric assay for low density lipoprotein receptors in human peripheral blood mononuclear cells. J. Lab. Clin. Med. 125: 479-486.
27. Oram, J. F., E. A. Brinton, and E. L. Bierman. 1983. Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. J. Clin. Invest. 72: 1611-1621.
28. Cuthbert, J., and P. E. Lipsky. 1990. Mitogenic stimulation alters the regulation of LDL receptor gene expression in human lymphocytes. J. Lipid Res. 31: 2067-2078.
29. Mazzone, T., K. Basheeruddin, L. Ping, and C. Schick. 1990. Relation of growth- and sterol-related regulatory pathways for low density lipoprotein receptor gene expression. J. Biol. Chem. 265: 5145-5149.
30. Goldstein, J. L., M. K. Sobhani, J. R. Faust, and M. S. Brown. 1976. Heterozygous familial hypercholesterolemia: failure of normal allele to compensate for mutant allele at a regulated genetic locus. Cell 9: 195-203.
31. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
32. Boyum, A. 1984. Separation of lymphocytes, granulocytes and monocytes from human blood using iodinated density gradient media. Methods Enzymol. 108: 88-102.
33. Clavey, V., S. Lestavel-Delattre, C. Copin, J. M. Bard, and J. C. Fruchart. 1995. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins C-I, C-II, C-III and E. Artherioscler. Thromb. Vas. Biol. 15: 963-971.
34. Alberts, A. W. 1988. Discovery, biochemistry and biology of lovastatin. Am. J. Cardiol. 62: 10J-15J.
35. Fairbanks, K. P., L. D. Witte, and D. S. Goodman. 1984. Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor. J. Biol. Chem. 259: 1546-1551.
36. Habenicht, A. J. R., J. A. Glomset, and R. Ross. 1980. Relation of cholesterol and mevalonate acid to cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J. Biol. Chem. 255: 5134-5140.
37. Jakobisiak, M., S. Bruno, J. S. Skierski, and Z. Darzynkiewicz. 1991. Cell cycle-specific effects of lovastatin. Proc. Natl. Acad. Sci. USA. 88: 3628-3632.
38. Keyomarsi, K., L. Sandoval, V. Band, and A. B. Pardee. 1991. Synchronization of tumour and normal cells from GI to multiple cell cycles by lovastatin. Cancer Res. 51: 3602-3609.
39. Terpstra, A. H. M., C. J. H. Woodward, and F. J. Sanchez-Muniz. 1980. Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoprotein from small volumes of scrum. Anal. Biochem. 111: 149-157.
40. Peterson, G. L. 1977. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83: 346-356.
41. Pitas, R. E., T. L. Innerarity, J. N. Weinstein, and R. W. Mahley. 1981. Acetoacetylated LDL used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis. 1: 177-185.
42. Beisiegel, U., W. J. Schneider, J. L. Goldstein, R. G. W. Anderson, and M. S. Brown. 1981. Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. J. Biol. Chem. 256: 11923-11931.
43. Stephan, Z. F., and E. C. Yurachek. 1993. Rapid flow cytometric assay for LDL receptor activity by DiI-labeled LDL. J. Lipid Res. 34: 325-330.
44. Lavergne, J. A., and A. M. del Llano. 1990. Assessment of cellular activation by flow cytometric methods. Pathobiology. 58: 107-117.
45. Galen, R. S., and S. R. Gambino, editors. 1977. Sensitivity, specificity, prevalence and incidence. In Beyond Normality: the Predictive Value and Efficiency of Medical Diagnoses. Wiley Biochemical Publications, New York. 10-14.
46. Krouwer, J. S. 1987. Cumulative distribution analysis graphs: an alternative to ROC curves (Tech Brief). Clin. Chem. 33: 2305-2306.
47. Bluestein, B. I., A. A. Luderer, D. Hess, D. Smith, K. K. Meyer, G. Boyle, and A. C. Carter. 1984. Measurement of ferritin-bearing peripheral mononuclear blood cells in cancer patients by immunoassays. Cancer Res. 44: 4131-4136.
48. Reid, M. C., M. S. Lachs, and A. R. Feinstein. 1995. Use of methodologic standards in diagnostic test research. Getting better but still not good. J. Am. Med. Assoc. 274: 645-651.
49. Huber, L. A., G. Bock, G. Jurgens, K. N. Traill, D. Schonitzer, and G. Wick. 1990. Increased expression of high-affinity low-density lipoprotein receptors on human T-blasts. InI. Arch. Allergy Appl. Immunol. 93: 205-211.
50. Hiramatsu, K., H. Sakai, M. Endoh, and S. Arimori. 1980. Surface properties of LDL-binding lymphocytes in human peripheral blood. Immunology. 39: 311-316.
51. Edwards, C. A., and G. R. Crabtree. 1989. Reguation of cell growth and activation. In Advances in Regulation of Cell Growth. Vol. 1. J. J. Mond, J. C. Cambier, and A. Weiss, editors. Raven Press Ltd., New York. 93-118.
52. Auwerx, J. H., A. Chait, G. Wolfbauer, and S. S. Deeb. 1989. Involvement of second messengers in regulation of the low density lipoprotein receptor gene. Mol. Cell Biol. 9: 2298-2302.
53. Makar, R. S. J., P. E. Lipsky, and J. A. Cuthbert. 1994. Non-sterol regulation of low density lipoprotein receptor gene expression in T cells. J. Lipid Res. 35: 1888-1895.
54. Mazzone, T., K. Basheeruddin, L. Ping, and C. Schick. 1990. Relation of growth- and sterol-related regulatory pathways for low density lipoprotein receptor gene expression. J. Biol. Chem. 269: 5145-5149.
55. Rivnay, B., S. Bergman, M. Shinitzky, and A. Globerson. 1980. Correlations between membrane viscosity, serum cholesterol, lymphocyte activation and aging in man. Mech. Ageing Dev. 12: 119-125.
56. Kruth, H. S., I. Auigan, W. Gamble, and M. Vaughan. 1979. Effect of cell density of binding and uptake of low density lipoproteins by human fibroblasts. J. Cell Biol. 83: 588-594.
57. Goldstein, J. L., M. S. Brown, and N. J. Stone. 1977. Genetics of the LDL receptor: evidence that mutations affecting binding and internalization are allelic. Cell. 12: 629-641.
58. Stewart, C. C., and B. Hamill. 1981. Effect of cell concentration on lymphocyte response to phytohemagglutinin. J. Reticuloendathelial Soc. 29: 79-88.
59. Sundqvist, K. G., and L. Wanger. 1981. Anchorage and lymphocyte function II. Contact with non-cellular surfaces, cell density and T-cell activation. Immunology. 43: 573-580.
60. Sites, D. P. 1994. Clinical laboratory methods for detection of cellular immunity. In Basic and Clinical Immunology. 8th ed. D. P. Stites, A. I. Terr, and T. G. Parslow, editors. Appleton and Lange, East Norwalk, CT.
61. Maluish, A. E., and D. M. Strong. 1986. Lymphocyte proliferation. In Manual of Clinical Laboratory Immunology. 3rd ed. N. R. Rose, H. Friedman, and J. L. Fahey, editors. American Society for Microbiology, Washington, DC. 274-281.
62. Ulmer, A. J., W. Scholz, and H. D. Flad. 1984. A new ultra-microculture system I. Stimulation of human T lymphocytes by phytohemagglutinin (PHA). J. Immunol. Methods. 68: 285-295.
63. Tybjaerg-Hansen, A., J. Gallagher, J. Vincent, R. Houlston, P. Talmud, A. M. Dunning, M. Seed, A. Hamsten, S. E. Humphries, and N. B. Myant. 1990. Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Arteriosclerosis. 80: 235-242.
64. Myant, N. B., J. Gallagher, B. L. Knight, S. N. McCarthy, J. Frostegard, J. Nilsson, A. Hamsten, P. Talmud, and S. E. Humphries. 1991. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function. Arterioscler. Thromb. 11: 691-703.
65. Matsuo, I., K. Yoshino, A. Ozawa, and M. Ohkido. 1981. Phytosterolemia and type IIa hyperlipoproteinemia with tuberous xanthomas. J. Am. Acad. Dermatol. 4: 47-49.
66. Low, L. C. K., H. J. Lin, K. S. Lau, A. W. C. Kung, and C. Y. Yeung. 1991. Phytosterolemia and pseudohomozygous type II hypercholesterolemia in two Chinese patients. J. Pediatr. 118: 746-749.
67. Austin, M. A., H. Horowitz, E. Wijsman, R. M. Krauss, and J. Brunzell. 1992. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia. Atherosclerosis. 92: 67-77.
68. Corsini, A., P. Roma, D. Sommariva, R. Fumagalli, and A. L. Catapano. 1986. Autoantibody to the low density lipoprotein receptor in a subject affected by severe hypercholesterolemia. J. Clin. Invest. 78: 940-946.
69. Sirtori, C. R., A. L. Catapano, G. Franceschini, A. Corsini, G. Noseda, C. Fragiacomo, E. Panzeri, V. Vaccarino, S. Guenzi, G. Casari, and F. Baralle. 1991. Aortic and coronary atheromatosis in a woman with severe hypercholesterolemia without LDL receptor alterations. Eur. Heart J. 12: 818-824.